Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
| Image |  |
|---|---|
| Description | preprint |
| Author/s |
author: Uğur Şahin Kathrin Jansen Vanessa Raabe Kena A Swanson David R Cooper Kenneth Koury Nicholas Kitchin Judith Absalon Kirsten E Lyke Warren Kalina Mark J Mulligan Kathleen Neuzil Ann R Falsey Alejandra Gurtman William C. Gruber Stephen Lockhart Robert W Frenck Philip R Dormitzer Pei-Yong Shi |
| Publication date | July 1, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |